BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10728909)

  • 1. Etoposide with or without mannitol for the treatment of recurrent or primarily unresponsive brain tumors: a Children's Cancer Group Study, CCG-9881.
    Kobrinsky NL; Packer RJ; Boyett JM; Stanley P; Shiminski-Maher T; Allen JC; Garvin JH; Stewart DJ; Finlay JL
    J Neurooncol; 1999; 45(1):47-54. PubMed ID: 10728909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors.
    Needle MN; Molloy PT; Geyer JR; Herman-Liu A; Belasco JB; Goldwein JW; Sutton L; Phillips PC
    Med Pediatr Oncol; 1997 Jul; 29(1):28-32. PubMed ID: 9142202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide.
    Chamberlain MC
    Arch Neurol; 1997 May; 54(5):554-8. PubMed ID: 9152112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.
    Finlay JL; Goldman S; Wong MC; Cairo M; Garvin J; August C; Cohen BH; Stanley P; Zimmerman RA; Bostrom B; Geyer JR; Harris RE; Sanders J; Yates AJ; Boyett JM; Packer RJ
    J Clin Oncol; 1996 Sep; 14(9):2495-503. PubMed ID: 8823328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent cerebellar gliomas: salvage therapy with oral etoposide.
    Chamberlain MC
    J Child Neurol; 1997 Apr; 12(3):200-4. PubMed ID: 9130095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic oral VP-16 for recurrent medulloblastoma.
    Chamberlain MC; Kormanik PA
    Pediatr Neurol; 1997 Oct; 17(3):230-4. PubMed ID: 9390699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study.
    Fouladi M; Nicholson HS; Zhou T; Laningham F; Helton KJ; Holmes E; Cohen K; Speights RA; Wright J; Pollack IF;
    Cancer; 2007 Dec; 110(11):2535-41. PubMed ID: 17932894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-irradiation chemotherapy in children with high-grade astrocytoma: tumor response to two cycles of the '8-drugs-in-1-day' regimen. A Childrens Cancer Group study, CCG-945.
    Finlay JL; Geyer JR; Turski PA; Yates AJ; Boyett JM; Allen JC; Packer RJ
    J Neurooncol; 1994; 21(3):255-65. PubMed ID: 7699420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
    Nicholson HS; Kretschmar CS; Krailo M; Bernstein M; Kadota R; Fort D; Friedman H; Harris MB; Tedeschi-Blok N; Mazewski C; Sato J; Reaman GH
    Cancer; 2007 Oct; 110(7):1542-50. PubMed ID: 17705175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.
    Newton HB; Slivka MA; Stevens CL; Bourekas EC; Christoforidis GA; Baujan MA; Chakeres DW
    J Neurooncol; 2002 Jan; 56(1):79-86. PubMed ID: 11949830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
    Korones DN; Smith A; Foreman N; Bouffet E
    Pediatr Blood Cancer; 2006 Jul; 47(1):37-41. PubMed ID: 16047359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
    Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
    Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of sequential high-dose chemotherapy and peripheral blood stem cell support for pediatric central nervous system malignancies.
    Jakacki RI; Jamison C; Heifetz SA; Caldemeyer K; Hanna M; Sender L
    Med Pediatr Oncol; 1997 Dec; 29(6):553-9. PubMed ID: 9324343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of recurrent medulloblastoma to low-dose oral etoposide.
    Ashley DM; Meier L; Kerby T; Zalduondo FM; Friedman HS; Gajjar A; Kun L; Duffner PK; Smith S; Longee D
    J Clin Oncol; 1996 Jun; 14(6):1922-7. PubMed ID: 8656261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of surveillance magnetic resonance imaging (MRI) scanning in detecting recurrent brain tumors in asymptomatic children.
    Korones DN; Butterfield R; Meyers SP; Constine LS
    J Neurooncol; 2001 May; 53(1):33-8. PubMed ID: 11678428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
    Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
    Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors.
    Pajtler KW; Tippelt S; Siegler N; Reichling S; Zimmermann M; Mikasch R; Bode U; Gnekow A; Pietsch T; Benesch M; Rutkowski S; Fleischhack G
    J Neurooncol; 2016 Jul; 128(3):463-71. PubMed ID: 27147083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumors.
    Fiorillo A; Maggi G; Greco N; Migliorati R; D'Amico A; De Caro MD; Sabbatino MS; Buffardi F
    J Neurooncol; 2004 Jan; 66(1-2):179-85. PubMed ID: 15015784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG).
    Davidson A; Gowing R; Lowis S; Newell D; Lewis I; Dicks-Mireaux C; Pinkerton CR
    Eur J Cancer; 1997 Oct; 33(11):1816-22. PubMed ID: 9470839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.